Sign in

    Meeshanthini (Meesha) V. Dogan

    Chief Executive Officer at Cardio Diagnostics Holdings Inc
    Board
    Since 2017
    Age
    36 years
    Education
    Earned a PhD in Biomedical Engineering and BSE/MS degrees in Chemical Engineering from the University of Iowa.
    Tenure
    Has served as Chief Executive Officer and director at the company since its inception in 2017.

    Also at Cardio Diagnostics Holdings Inc

    R(P
    Robert (Rob) Philibert
    Chief Medical Officer
    EL
    Elisa Luqman
    Chief Financial Officer (CFO)
    TD
    Timur Dogan
    Chief Technology Officer (CTO)

    About

    Holding a robust academic background, she earned advanced degrees in Biomedical and Chemical Engineering from the University of Iowa, which laid the foundation for her technical expertise and leadership.

    In 2017, she co-founded the organization and has since served as Chief Executive Officer and director, playing a pivotal role in driving innovation in cardiovascular diagnostics through integrated genetic-epigenetic technology.

    Motivated by a personal history of heart disease in her family, she has leveraged over 13 years of experience bridging medicine, engineering, and artificial intelligence to develop solutions for early detection and prevention of cardiovascular conditions, garnering industry recognition along the way.

    $CDIO Performance Under Meeshanthini (Meesha) V. Dogan

    Past Roles

    OrganizationRoleDate RangeDetails
    Legacy CardioCo-Founder2017 - UnknownFounded to commercialize technology for cardiovascular disease prevention and later became part of CDIO through a business combination

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$300,000 Annually Fixed annual salary reflecting skill set, experience, role, and responsibilities
    All Other Compensation$11,000 Annually Includes 401(k) contributions and health and dental insurance coverage

    Performance Compensation

    Data from  FY 2024

    No information available on performance compensation for 2024